Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01220947
What this trial is testing

Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 421
Large-scale testing (Phase 3)Study completedNCT00039962
What this trial is testing

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Large-scale testing (Phase 3)UnknownNCT02732405
What this trial is testing

Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis

Who this might be right for
Hepatitis CCompensated Cirrhosis
Istituto Clinico Humanitas 120
Not applicableStudy completedNCT01342003
What this trial is testing

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliera San Camillo Forlanini 388
Testing effectiveness (Phase 2)Study completedNCT01183169
What this trial is testing

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Who this might be right for
Hepatitis C
Debiopharm International SA 459
Not applicableUnknownNCT04428346
What this trial is testing

A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 400
Not applicableUnknownNCT06104046
What this trial is testing

Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis

Who this might be right for
Hepatitis C Virus
Assiut University 50
Not applicableStudy completedNCT01908660
What this trial is testing

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Who this might be right for
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Valme University Hospital 192
Large-scale testing (Phase 3)Study completedNCT00158496
What this trial is testing

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 100
Not applicableLooking for participantsNCT05870969
What this trial is testing

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Who this might be right for
Carcinoma, HepatocellularHepatitis C, ChronicHepatitis B, Chronic+2 more
Ruijin Hospital 20,000
Testing effectiveness (Phase 2)Study completedNCT00423670
What this trial is testing

Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 765
Testing effectiveness (Phase 2)WithdrawnNCT00930995
What this trial is testing

Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Kaiser Permanente
Large-scale testing (Phase 3)UnknownNCT03540212
What this trial is testing

Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus

Who this might be right for
Chronic HCV Infection
Ain Shams University 50
Large-scale testing (Phase 3)Study completedNCT02023112
What this trial is testing

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
AbbVie 171
Large-scale testing (Phase 3)Study completedNCT03080415
What this trial is testing

Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir

Who this might be right for
Hepatitis C Genotype 4
Yassin Abdelghaffar Charity Center for Liver Disease and Research 40
Testing effectiveness (Phase 2)Study completedNCT00851890
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
AbbVie (prior sponsor, Abbott) 30
Not applicableStudy completedNCT01159613
What this trial is testing

Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Who this might be right for
Chronic Hepatitis C Viral Infection
Ziv Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488
Large-scale testing (Phase 3)Study completedNCT00624325
What this trial is testing

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 30
Next Page